r 59022 has been researched along with Duncan Disease in 2 studies
R 59022: diacylglycerol kinase inhibitor; structure given in first source; platelet activator factor antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Velnati, S | 1 |
| Ruffo, E | 2 |
| Massarotti, A | 1 |
| Talmon, M | 1 |
| Varma, KSS | 1 |
| Gesu, A | 1 |
| Fresu, LG | 1 |
| Snow, AL | 2 |
| Bertoni, A | 1 |
| Capello, D | 1 |
| Tron, GC | 1 |
| Graziani, A | 2 |
| Baldanzi, G | 2 |
| Malacarne, V | 1 |
| Larsen, SE | 1 |
| Das, R | 1 |
| Patrussi, L | 1 |
| Wülfing, C | 1 |
| Biskup, C | 1 |
| Kapnick, SM | 1 |
| Verbist, K | 1 |
| Tedrick, P | 1 |
| Schwartzberg, PL | 1 |
| Baldari, CT | 1 |
| Rubio, I | 1 |
| Nichols, KE | 1 |
2 other studies available for r 59022 and Duncan Disease
| Article | Year |
|---|---|
Identification of a novel DGKα inhibitor for XLP-1 therapy by virtual screening.
Topics: Cell Death; Computer Simulation; Diacylglycerol Kinase; Drug Evaluation, Preclinical; Humans; Lympho | 2019 |
Inhibition of diacylglycerol kinase α restores restimulation-induced cell death and reduces immunopathology in XLP-1.
Topics: Animals; CD8-Positive T-Lymphocytes; Cell Death; Cytokines; Diacylglycerol Kinase; Gene Silencing; H | 2016 |